Document is current

Any future updates will be listed below

Erster Wirkstoff mit tumoragnostischer Indikation in der EU

Crossref DOI link: https://doi.org/10.1007/s15014-020-2399-5

Published Online: 2020-08-19

Published Print: 2020-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark